Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland · Delayed Price · Currency is CHF 55.50
-0.40 (-0.72%)
Aug 15, 2025, 5:30 PM CET
Cosmo Pharmaceuticals Market Cap
Cosmo Pharmaceuticals has a market cap or net worth of 884.61 million as of August 15, 2025. Its market cap has decreased by -23.43% in one year.
Market Cap
884.61M
Enterprise Value
775.16M
Revenue
170.24M
Ranking
n/a
PE Ratio
16.20
Stock Price
55.50
Market Cap Chart
Since March 12, 2007, Cosmo Pharmaceuticals's market cap has increased from 194.90M to 884.61M, an increase of 353.87%. That is a compound annual growth rate of 8.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 884.61M | -13.45% |
| Dec 30, 2024 | 1.02B | 24.91% |
| Dec 29, 2023 | 818.27M | -18.39% |
| Dec 30, 2022 | 1.00B | -9.22% |
| Dec 30, 2021 | 1.10B | -10.15% |
| Dec 30, 2020 | 1.23B | 9.61% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 214.27B |
| Novartis AG | 188.78B |
| Lonza Group AG | 38.89B |
| Alcon | 34.73B |
| Galderma Group AG | 31.01B |
| Sandoz Group AG | 20.60B |
| Straumann Holding AG | 14.93B |
| Sonova Holding AG | 13.47B |